135 related articles for article (PubMed ID: 19228652)
1. Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis.
Low AH; Johnson SR; Lee P
J Rheumatol; 2009 Apr; 36(4):787-93. PubMed ID: 19228652
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological features of systemic sclerosis in a Chinese cohort.
Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
[TBL] [Abstract][Full Text] [Related]
3. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.
Sujau I; Ng CT; Sthaneshwar P; Sockalingam S; Cheah TE; Yahya F; Jasmin R
Int J Rheum Dis; 2015 May; 18(4):459-65. PubMed ID: 24618222
[TBL] [Abstract][Full Text] [Related]
4. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
5. Ethnic Variations in Systemic Sclerosis Disease Manifestations, Internal Organ Involvement, and Mortality.
Al-Sheikh H; Ahmad Z; Johnson SR
J Rheumatol; 2019 Sep; 46(9):1103-1108. PubMed ID: 30824634
[TBL] [Abstract][Full Text] [Related]
6. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
7. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
Steen V; Domsic RT; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2012 Sep; 64(9):2986-94. PubMed ID: 22576620
[TBL] [Abstract][Full Text] [Related]
8. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
9. Anti-U3 RNP autoantibodies in systemic sclerosis.
Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population.
Liu C; Hou Y; Yang Y; Xu D; Li L; Li J; Wen X; Zeng X; Zhang F; Li Y
Clin Chim Acta; 2019 Apr; 491():121-125. PubMed ID: 30685360
[TBL] [Abstract][Full Text] [Related]
12. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
15. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
[TBL] [Abstract][Full Text] [Related]
16. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody profiles delineate distinct subsets of scleromyositis.
Leclair V; D'Aoust J; Gyger G; Landon-Cardinal O; Meyer A; O'Ferrall E; Karamchandani J; Massie R; Ellezam B; Satoh M; Troyanov Y; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Mar; 61(3):1148-1157. PubMed ID: 34146090
[TBL] [Abstract][Full Text] [Related]
18. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.
Jaeger VK; Tikly M; Xu D; Siegert E; Hachulla E; Airò P; Valentini G; Matucci Cerinic M; Distler O; Cozzi F; Carreira P; Allanore Y; Müller-Ladner U; Ananieva LP; Balbir-Gurman A; Distler JHW; Czirják L; Li M; Henes J; Jimenez SA; Smith V; Damjanov N; Denton CP; DelGaldo F; Saketkoo LA; Walker UA;
Rheumatology (Oxford); 2020 Jul; 59(7):1684-1694. PubMed ID: 31680161
[TBL] [Abstract][Full Text] [Related]
20. Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies.
Nakane S; Umeda M; Kawashiri SY; Mukaino A; Ichinose K; Higuchi O; Maeda Y; Nakamura H; Matsuo H; Kawakami A
Arthritis Res Ther; 2020 Feb; 22(1):32. PubMed ID: 32085768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]